Mitchell Creem, Director at Clinigence Holdings, Inc. (CLNH), bought 31,746 shares at $20000.00 ($634.9M) on 2020-08-12, disclosed to the SEC on 2020-09-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.